In another cohort, positive SRC-3 expression was found in 54.6% of anaplastic thyroid carcinoma (ATC), an aggressive form of thyroid cancer, but SRC-3 levels in PTC and follicular thyroid carcinoma (FTC) were not significantly different from normal thyroid tissues [52]. The gene discussed is NCOA3; the disease is thyroid cancer.